- Home
- JOB vs AYTU Comparison
JOB vs AYTU Comparison
Compare JOB & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JOB
- AYTU
- Stock Information
- Founded
- JOB 1893
- AYTU N/A
- Country
- JOB United States
- AYTU United States
- Employees
- JOB N/A
- AYTU N/A
- Industry
- JOB Diversified Commercial Services
- AYTU Biotechnology: Pharmaceutical Preparations
- Sector
- JOB Consumer Discretionary
- AYTU Health Care
- Exchange
- JOB Nasdaq
- AYTU Nasdaq
- Market Cap
- JOB 21.2M
- AYTU 19.7M
- IPO Year
- JOB N/A
- AYTU N/A
- Fundamental
- Price
- JOB $0.19
- AYTU $2.26
- Analyst Decision
- JOB
- AYTU Strong Buy
- Analyst Count
- JOB 0
- AYTU 2
- Target Price
- JOB N/A
- AYTU $10.00
- AVG Volume (30 Days)
- JOB 202.6K
- AYTU 79.7K
- Earning Date
- JOB 08-13-2025
- AYTU 09-25-2025
- Dividend Yield
- JOB N/A
- AYTU N/A
- EPS Growth
- JOB N/A
- AYTU N/A
- EPS
- JOB N/A
- AYTU N/A
- Revenue
- JOB $108,752,000.00
- AYTU $81,659,000.00
- Revenue This Year
- JOB $43.94
- AYTU N/A
- Revenue Next Year
- JOB N/A
- AYTU $2.00
- P/E Ratio
- JOB N/A
- AYTU $12.32
- Revenue Growth
- JOB N/A
- AYTU 0.41
- 52 Week Low
- JOB $0.17
- AYTU $0.95
- 52 Week High
- JOB $0.51
- AYTU $2.85
- Technical
- Relative Strength Index (RSI)
- JOB 37.83
- AYTU 46.67
- Support Level
- JOB $0.19
- AYTU $2.25
- Resistance Level
- JOB $0.21
- AYTU $2.39
- Average True Range (ATR)
- JOB 0.01
- AYTU 0.12
- MACD
- JOB -0.00
- AYTU 0.00
- Stochastic Oscillator
- JOB 0.50
- AYTU 46.88
About JOB GEE Group Inc.
GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.